Role of Glucagon, Catecholamines, and Growth Hormone in Human Glucose Counterregulation
Open accessThe DOI matches its Crossref record; 51 of the 53 references it cites were found in a registry or an index.
Abstract
To further characterize mechanisms of glucose counterregulation in man, the effects of pharmacologically inducd deficiencies of glucagon, growth hormone, and catecholamines (alone and in combination) on recovery of plasma glucose from insulin-induced hypoglycemia and attendant changes in isotopically ([3-(3)H]glucose) determined glucose fluxes were studied in 13 normal subjects. In control studies, recovery of plasma glucose from hypoglycemia was primarily due to a compensatory increase in glucose production; the temporal relationship of glucagon, epinephrine, cortisol, and growth hormone responses with the compensatory increase in glucose appearance was compatible with potential participation of all these hormones in acute glucose counterregulation. Infusion of somatostatin (combined deficiency of glucagon and growth hormone) accentuated insulin-induced hypoglycemia (plasma glucose nadir: 36+/-2 ng/dl during infusion of somatostatin vs. 47+/-2 mg/dl in control studies, P < 0.01) and impaired restoration of normoglycemia (plasma glucose at min 90: 73+/-3 mg/dl at end of somatostatin infusion vs. 92+/-3 mg/dl in control studies, P<0.01). This impaired recovery of plasma glucose was due to blunting of the compensatory increase in glucose appearance since glucose disappearance was not augmented, and was attributable to suppression of glucagon secretion rather than growth hormone secretion since these effects of somatostatin were not observed during simultaneous infusion of somatostatin and glucagon whereas infusion of growth hormone along with somatostatin did not prevent the effect of somatostatin. The attenuated recovery of plasma glucose from hypoglycemia observed during somatostatin-induced glucagon deficiency was associated with plasma epinephrine levels twice those observed in control studies. Infusion of phentolamine plus propranolol (combined alpha-and beta-adrenergic blockade) had no effect on plasma glucose or glucose fluxes after insulin administration. However, infusion of somatostatin along with both phentolamine and propranolol further impaired recovery of plasma glucose from hypoglycemia compared to that observed with somatostatin alone (plasma glucose at end of infusions: 52+/-6 mg/dl for somatostatin-phentolamine-propranolol vs. 72+/-5 mg/dl for somatostatin alone, P < 0.01); this was due to further suppression of the compensatory increase in glucose appearance (maximal values: 1.93+/-0.41 mg/kg per min for somatostatin-phentolamine-propranolol vs. 2.86+/-0.32 mg/kg per min for somatostatin alone, P < 0.05). These results indicate that in man (a) restoration of normoglycemia after insulin-induced hypoglycemia is primarily due to a compensatory increase in glucose production; (b) intact glucagon secretion, but not growth hormone secretion, is necessary for normal glucose counterregulation, and (c) adrenergic mechanisms do not normally play an essential role in this process but become critical to recovery from hypoglycemia when glucagon secretion is impaired.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
Feinleib, M., & Zar, J. H. (1975) · Journal of the American Statistical Association · doi:10.2307/2285423 · Cited by 12,680
Zar, J. H. (1996) · Cited by 7,837
MURPHY, B. E. P. (1967) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-27-7-973 · Cited by 1,994
Hypoglycemia: A Potent Stimulus to Secretion of Growth Hormone
Roth, J., Glick, S. M., Yalow, R. S., & Berson, S. A. (1963) · Science · doi:10.1126/science.140.3570.987 · Cited by 669
Neural control of the endocrine pancreas.
Woods, S. C., & Porte, D. (1974) · Physiological Reviews · doi:10.1152/physrev.1974.54.3.596 · Cited by 630
ON THE HORMONAL REGULATION OF CARBOHYDRATE METABOLISM; STUDIES WITH C14 GLUCOSE.
DeBodo, R. C., Steele, R., ALTSZULER, N., Dunn, A., & Bishop, J. (1963) · PubMed · Cited by 532
Tissue effects of glucocorticoids
Baxter, J. D., & Forsham, P. H. (1972) · The American Journal of Medicine · doi:10.1016/0002-9343(72)90154-4 · Cited by 503
The Control of Glycogen Metabolism in the Liver
Hers, H. G. (1976) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.45.070176.001123 · Cited by 448
The control of glycogen metabolism in the liver
Hers, H. G., De Wulf, H., & Stalmans, W. (1970) · FEBS Letters · doi:10.1016/0014-5793(70)80569-5 · Cited by 414
Garber, A. J., Cryer, P. E., Santiago, J. V., Haymond, M. W., Pagliara, A. S., & Kipnis, D. M. (1976) · Journal of Clinical Investigation · doi:10.1172/jci108460 · Cited by 351
Self-citation
Cited by
Vinik, A. I., Maser, R. E., Mitchell, B. D., & Freeman, R. (2003) · Diabetes Care · doi:10.2337/diacare.26.5.1553 · Cited by 2,044
Neurobiology of food intake in health and disease
Morton, G. J., Meek, T. H., & Schwartz, M. W. (2014) · Nature Reviews Neuroscience · doi:10.1038/nrn3745 · Cited by 748
Dose-response characteristics for effects of insulin on production and utilization of glucose in man
Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1981) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1981.240.6.e630 · Cited by 703
Self-citationRIZZA, R. A., MANDARINO, L. J., & GERICH, J. E. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-1-131 · Cited by 696
Self-citationPhysiology and Pathophysiology of the Human Sympathoadrenal Neuroendocrine System
Bleich, H. L., Moore, M. J., & Cryer, P. E. (1980) · New England Journal of Medicine · doi:10.1056/nejm198008213030806 · Cited by 652
Self-citationα-Cells of the Endocrine Pancreas: 35 Years of Research but the Enigma Remains
Gromada, J., Franklin, I., & Wollheim, C. B. (2007) · Endocrine Reviews · doi:10.1210/er.2006-0007 · Cited by 581
Catecholaminergic Modulation of Corticotropin-Releasing Factor and Adrenocorticotropin Secretion
PLOTSKY, P. M., CUNNINGHAM, E. T., & WIDMAIER, E. P. (1989) · Endocrine Reviews · doi:10.1210/edrv-10-4-437 · Cited by 530
BONORA, E., MOGHETTI, P., ZANCANARO, C., CIGOLINI, M., QUERENA, M., CACCIATORI, V., CORGNATI, A., & MUGGEO, M. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-68-2-374 · Cited by 522
Service, F. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504273321707 · Cited by 503
Schwartz, N. S., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1987) · Journal of Clinical Investigation · doi:10.1172/jci112884 · Cited by 394
Self-citationWhite, N. H., Skor, D. A., Cryer, P. E., Levandoski, L. A., Bier, D. M., & Santiago, J. V. (1983) · New England Journal of Medicine · doi:10.1056/nejm198303033080903 · Cited by 391
Self-citationEffects of glucocorticoids on carbohydrate metabolism
Mcmahon, M., Gerich, J., & Rizza, R. (1988) · Diabetes/Metabolism Reviews · doi:10.1002/dmr.5610040105 · Cited by 390
Self-citationPancreatic Islet Transplantation in Humans: Recent Progress and Future Directions
Rickels, M. R., & Robertson, R. P. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00154 · Cited by 329
The Effect of Growth Hormone on Glucose Metabolism and Insulin Secretion in Man*
BRATUSCH-MARRAIN, P. R., SMITH, D., & DEFRONZO, R. A. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-5-973 · Cited by 321
Amiel, S. A., Tamborlane, W. V., Simonson, D. C., & Sherwin, R. S. (1987) · New England Journal of Medicine · doi:10.1056/nejm198705283162205 · Cited by 309
Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus
Epstein, F. H., Cryer, P. E., & Gerich, J. E. (1985) · New England Journal of Medicine · doi:10.1056/nejm198507253130405 · Cited by 273
Self-citationVentromedial hypothalamic lesions in rats suppress counterregulatory responses to hypoglycemia.
Borg, W. P., During, M. J., Sherwin, R. S., Borg, M. A., Brines, M. L., & Shulman, G. I. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117150 · Cited by 264
Evaluation of insulin sensitivity in clinical practice and in research settings
Monzillo, L. U., & Hamdy, O. (2003) · Nutrition Reviews · doi:10.1301/nr.2003.dec.397-412 · Cited by 259
Minireview: Glucagon in the Pathogenesis of Hypoglycemia and Hyperglycemia in Diabetes
Cryer, P. E. (2012) · Endocrinology · doi:10.1210/en.2011-1499 · Cited by 242
Self-citationDimitriadis, G. D., Maratou, E., Kountouri, A., Board, M., & Lambadiari, V. (2021) · Nutrients · doi:10.3390/nu13010159 · Cited by 241
Gerich, J. E. (1993) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(05)80207-1 · Cited by 224
Self-citationProtection by lactate of cerebral function during hypoglycaemia
Maran, A., Cranston, I., Lomas, J., Amiel, S. A., & Macdonald, I. (1994) · The Lancet · doi:10.1016/s0140-6736(94)90876-1 · Cited by 219
Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients
Allon, M., & Copkney, C. (1990) · Kidney International · doi:10.1038/ki.1990.284 · Cited by 220
Glutamate Is a Positive Autocrine Signal for Glucagon Release
Cabrera, O., Jacques-Silva, M. C., Speier, S., Yang, S.-N., Köhler, M., Fachado, A., Vieira, E., Zierath, J. R., Kibbey, R., Berman, D. M., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2008.03.004 · Cited by 217
König, M., Bulik, S., & Holzhütter, H.-G. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002577 · Cited by 202
Glucose counterregulation: prevention and correction of hypoglycemia in humans
Cryer, P. E. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.264.2.e149 · Cited by 198
Self-citationHerbel, G., & Boyle, P. J. (2000) · Cited by 199
(2011) · PubMed · Cited by 187
Akinmokun, A., Selby, P. L., Ramaiya, K., & Alberti, K. G. M. M. (1992) · Diabetic Medicine · doi:10.1111/j.1464-5491.1992.tb01813.x · Cited by 181
Metabolic effects of the nocturnal rise in cortisol on carbohydrate metabolism in normal humans.
Dinneen, S., Alzaid, A., Miles, J., & Rizza, R. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116832 · Cited by 175
Self-citationSIMONSON, D. C., TAMBORLANE, W. V., DeFRONZO, R. A., & SHERWIN, R. S. (1985) · Annals of Internal Medicine · doi:10.7326/0003-4819-103-2-184 · Cited by 123
SANTIAGO, J. V., CLARKE, W. L., SHAH, S. D., & CRYER, P. E. (1980) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-51-4-877 · Cited by 166
Self-citationHypoglycaemia in Elderly Patients with Diabetes Mellitus: Causes and Strategies for Prevention
Chelliah, A., & Burge, M. R. (2004) · Drugs & Aging · doi:10.2165/00002512-200421080-00003 · Cited by 165
Neuroendocrine responses to hypoglycemia
Tesfaye, N., & Seaquist, E. R. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05820.x · Cited by 164
Taylor, R., & Agius, L. (1988) · Biochemical Journal · doi:10.1042/bj2500625 · Cited by 164
Myocardial composition and function in diabetes. The effects of chronic insulin use.
Regan, T. J., Wu, C. F., Yeh, C. K., Oldewurtel, H. A., & Haider, B. (1981) · Circulation Research · doi:10.1161/01.res.49.6.1268 · Cited by 160
“Additional hormone administration over the subsequent hours in these animals with normal fasting blood glucose levels was not used so as to avoid hypoglycemia and the confounding effects of increased blood levels of the cardioactive hormones, epinephrine and glucagon (Rizzo et al., 1979).”
BackgroundPreserved Insulin Secretion and Insulin Independence in Recipients of Islet Autografts
Pyzdrowski, K. L., Kendall, D. M., Halter, J. B., Nakhleh, R. E., Sutherland, D. E. R., & Robertson, R. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199207233270402 · Cited by 152
Hypoglycemia-associated autonomic failure in diabetes
Cryer, P. E. (2001) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2001.281.6.e1115 · Cited by 152
Gerich, J., Cryer, P., & Rizza, R. (1980) · Metabolism · doi:10.1016/0026-0495(80)90026-8 · Cited by 147
Self-citationNPY/AgRP neurons are not essential for feeding responses to glucoprivation
Luquet, S. H., Phillips, C. T., & Palmiter, R. D. (2006) · Peptides · doi:10.1016/j.peptides.2006.08.036 · Cited by 158
Contribution of cortisol to glucose counterregulation in humans
De Feo, P., Perriello, G., Torlone, E., Ventura, M. M., Fanelli, C., Santeusanio, F., Brunetti, P., Gerich, J. E., & Bolli, G. B. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.257.1.e35 · Cited by 134
Self-citationFreeman, R. L. (2014) · Handbook of clinical neurology · doi:10.1016/b978-0-444-53480-4.00006-0 · Cited by 162
Torlone, E., Fanelli, C. G., Rambotti, A. M., Kassi, G., Modarelli, F., Vincenzo, A. D., Epifano, L., Ciofetta, M., Pampanelli, S., Brunetti, P., et al. (1994) · Diabetologia · doi:10.1007/bf00417697 · Cited by 136
Exercise and Type 1 Diabetes (T1DM)
Galassetti, P., & Riddell, M. C. (2013) · Comprehensive Physiology · doi:10.1002/cphy.c110040 · Cited by 129
“both centrally (hypothalamus) and peripherally (pancreatic islets), and corrective actions are undertaken if glucose concentration is too high (with insulin release) or too low (with release of the counterregulatory hormones cortisol, glucagon, epinephrine, and norepinephrine) (65, 67, 68, 257).”
PRIOR THIAZIDE DIURETIC TREATMENT INCREASES ADRENALINE-INDUCED HYPOKALAEMIA
Struthers, A. D., Whitesmith, R., & Reid, J. L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)92140-2 · Cited by 124
More on Neuropathy from Pyridoxine Abuse
Berger, A., & Schaumburg, H. H. (1984) · New England Journal of Medicine · doi:10.1056/nejm198410113111513 · Cited by 127
Octreotide reverses hyperinsulinemia and prevents hypoglycemia induced by sulfonylurea overdoses.
Boyle, P. J., Justice, K., Krentz, A. J., Nagy, R. J., & Schade, D. S. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.76.3.8445035 · Cited by 125
Baxter, R. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.9.2700 · Cited by 127
Pehling, G., Tessari, P., Gerich, J. E., Haymond, M. W., Service, F. J., & Rizza, R. A. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111519 · Cited by 119
“5 M perchloric acid for subsequent measurement of tritiated glucose specific activity as previously described (14).”
MethodSelf-citationEndocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: A review
Fish, H. R., Chernow, B., & O'Brian, J. T. (1986) · Metabolism · doi:10.1016/0026-0495(86)90245-3 · Cited by 117
Van De Borne, P., Hausberg, M., Hoffman, R. P., Mark, A. L., & Anderson, E. A. (1999) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1999.276.1.r178 · Cited by 119
“Measurements were performed during a 10-min baseline period before an intravenous injection of 5 mg of propranolol (26).”
MethodThe role of leptin in diabetes: metabolic effects
Meek, T. H., & Morton, G. J. (2016) · Diabetologia · doi:10.1007/s00125-016-3898-3 · Cited by 132
Boden, G., Reichard, G. A., Hoeldtke, R. D., Rezvani, I., & Owen, O. E. (1981) · New England Journal of Medicine · doi:10.1056/nejm198111123052007 · Cited by 118
Demonstration of a role for growth hormone in glucose counterregulation
De Feo, P., Perriello, G., Torlone, E., Ventura, M. M., Santeusanio, F., Brunetti, P., Gerich, J. E., & Bolli, G. B. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.6.e835 · Cited by 116
Self-citationCryer, P. E., Rizza, R. A., Haymond, M. W., & Gerich, J. E. (1980) · Metabolism · doi:10.1016/0026-0495(80)90019-0 · Cited by 115
Self-citationTorlone, E., Rambotti, A. M., Perriello, G., Botta, G., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1991) · Diabetologia · doi:10.1007/bf00500383 · Cited by 114
“, USA), glucose specific activity [33], insulin [34], C-peptide [35], and non-esterified fatty acids (NEFA) [36] by previously described methods.”
MethodHigh residual C-peptide likely contributes to glycemic control in type 1 diabetes
Rickels, M. R., Evans-Molina, C., Bahnson, H. T., Ylescupidez, A., Nadeau, K. J., Hao, W., Clements, M. A., Sherr, J. L., Pratley, R. E., Hannon, T. S., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci134057 · Cited by 113
Hope, K. M., Tran, P. O. T., Zhou, H., Oseid, E., Leroy, E., & Robertson, R. P. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1488 · Cited by 112
Popp, D. A., Shah, S. D., & Cryer, P. E. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110455 · Cited by 112
Self-citationPetrides, A. S., STANLEY, T., Matthews, D. E., Vogt, C., Bush, A. J., & Lambeth, H. (1998) · Hepatology · doi:10.1002/hep.510280119 · Cited by 111
Bolli, G. B., Tsalikian, E., Haymond, M. W., Cryer, P. E., & Gerich, J. E. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111359 · Cited by 108
Self-citationCarcinoembryonic Antigen-Related Cell Adhesion Molecule 1
DeAngelis, A. M., Heinrich, G., Dai, T., Bowman, T. A., Patel, P. R., Lee, S. J., Hong, E., Jung, D. Y., Aßmann, A., Kulkarni, R. N., et al. (2008) · Diabetes · doi:10.2337/db08-0379 · Cited by 123
Mudaliar, S., Henry, R. R., Boden, G., Smith, S., Chalamandaris, A.-G., Duchesne, D., Iqbal, N., & List, J. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0167 · Cited by 106
Insulin and glucagon in prevention of hypoglycemia during exercise in humans
Hirsch, I. B., Marker, J. C., Smith, L. J., Spina, R. J., Parvin, C. A., Holloszy, J. O., & Cryer, P. E. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.5.e695 · Cited by 102
Self-citationZhou, H., Tran, P. O. T., Yang, S., Zhang, T., LeRoy, E., Oseid, E., & Robertson, R. P. (2004) · Diabetes · doi:10.2337/diabetes.53.6.1482 · Cited by 101
PHYSIOLOGY OF GLUCOSE COUNTERREGULATION TO HYPOGLYCEMIA
Bolli, G. B., & Fanelli, C. G. (1999) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/s0889-8529(05)70083-9 · Cited by 99
Sheridan, M. A., Woo, N. Y. S., & Bern, H. A. (1985) · Journal of Experimental Zoology · doi:10.1002/jez.1402360106 · Cited by 96
Niakan, E., Harati, Y., & Comstock, J. P. (1986) · Metabolism · doi:10.1016/0026-0495(86)90205-2 · Cited by 93
Body, J.-J., Cryer, P. E., Offord, K. P., & Heath, H. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110802 · Cited by 89
Self-citationPerriello, G., Feo, P. D., Torlone, E., Fanelli, C. G., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1990) · Diabetologia · doi:10.1007/bf00586461 · Cited by 90
Torlone, E., Britta, M., Rambotti, A. M., Perriello, G., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1993) · Diabetes Care · doi:10.2337/diacare.16.10.1347 · Cited by 86
“Analytical procedures Arterialized venous blood samples were collected at 5- to 10-min intervals and assayed for glucose (determined at bedside by means of a Beckman Glucose Analyzer, Beckman Instruments, Fullerton, CA), glucose specific activity (30), insulin (31), C-peptide (32), and NEFAs by a colorimetric method u…”
MethodPerriello, G., Feo, P. D., Torlone, E., Fanelli, C. G., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1991) · Diabetologia · doi:10.1007/bf00404020 · Cited by 89
“Glucose specific activity [35] and plasma free insulin [36] were determined by previously decribed methods.”
MethodEstimation and kinetic analysis of insulin-independent glucose uptake in human subjects
Gottesman, I., Mandarino, L., & Gerich, J. (1983) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1983.244.6.e632 · Cited by 85
Self-citationInsulin, glucagon, and catecholamines in prevention of hypoglycemia during fasting
Boyle, P. J., Shah, S. D., & Cryer, P. E. (1989) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1989.256.5.e651 · Cited by 84
Self-citationImpact of Hypoglycemia on Brain Metabolism During Diabetes
Rehni, A. K., & Dave, K. R. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1044-6 · Cited by 89
“Epinephrine activates adrenergic pathways that increase blood glucose levels by modulating the secretion of insulin and glucagon, and the rates of glucose uptake and utilization [21, 22].”
Role of hepatic autoregulation in defense against hypoglycemia in humans.
Bolli, G., De Feo, P., Perriello, G., De Cosmo, S., Ventura, M., Campbell, P., Brunetti, P., & Gerich, J. E. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111869 · Cited by 79
Self-citationEffect of Opiate and Adrenergic Blockers on the Gut Motor Response to Centrally Acting Stimuli
Stanghellini, V., Malagelada, J., Zinsmeister, A. R., Go, V. L. W., & Kao, P. C. (1984) · Gastroenterology · doi:10.1016/s0016-5085(84)80070-0 · Cited by 81
Lager, I., Attvall, S., Eriksson, B. M., Schenk, H., & Smith, U. (1986) · Diabetologia · doi:10.1007/bf00506530 · Cited by 90
“glucagon release is impaired [6]; this occurs frequently in Type I (insulin-dependent) diabetes [7, 8].”
BackgroundNeuropeptide Y Is Required for Hyperphagic Feeding in Response to Neuroglucopenia
Sindelar, D. K., Marie, L. S., Miura, G. I., Palmiter, R. D., McMinn, J. E., Morton, G. J., & Schwartz, M. W. (2004) · Endocrinology · doi:10.1210/en.2003-1727 · Cited by 87
Mechanisms of insulin resistance in man
Rizza, R. A., Mandarino, L. J., & Gerich, J. E. (1981) · The American Journal of Medicine · doi:10.1016/0002-9343(81)90423-x · Cited by 79
Self-citationFanelli, C. G., De Feo, P., Porcellati, F., Perriello, G., Torlone, E., Santeusanio, F., Brunetti, P., & Bolli, G. B. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115809 · Cited by 77
Bingham, E., Dunn, J., Smith, D. M., Sutcliffe-Goulden, J., Reed, L. J., Marsden, P. K., & Amiel, S. A. (2005) · Diabetologia · doi:10.1007/s00125-005-1900-6 · Cited by 77
“S. A. Amiel (*) Medical School Building, Guy’s, King’s and St Thomas’ School of Medicine, King’s College, Denmark Hill Campus, Bessemer Road, London, SE5 9PJ, UK e-mail: stephanie.amiel@kcl.ac.uk Tel.: +44-207-3464161 Fax: +44-207-3463685 suppression of endogenous insulin, stimulation of glucagon secretion and sympath…”
BackgroundVariable Deterioration in Cortical Function During Insulin-induced Hypoglycemia
Herold, K. C., Polonsky, K. S., Cohen, R. M., Levy, J., & Douglas, F. (1985) · Diabetes · doi:10.2337/diab.34.7.677 · Cited by 77
Tse, T. F., Clutter, W. E., Shah, S. D., & Cryer, P. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110967 · Cited by 73
Self-citationHormonal and metabolic response to hypoglycaemia in small for gestational age infants.
Hawdon, J. M., Weddell, A., Aynsley-Green, A., & Ward Platt, M. P. (1993) · Archives of Disease in Childhood · doi:10.1136/adc.68.3_spec_no.269 · Cited by 75
Insulin-counteracting hormones: Their impact on glucose metabolism
Bratusch-Marrain, P. R. (1983) · Diabetologia · doi:10.1007/bf00297384 · Cited by 82
The incretins: a link between nutrients and well-being
Burcelin, R. (2005) · British Journal of Nutrition · doi:10.1079/bjn20041340 · Cited by 70
“Indeed, the glucagon secretion is strongly dependent upon the autonomic nervous system (Rizza et al. 1979; Cryer, 1981; Gerich et al. 1990).”
Effects of insulin on the counterregulatory response to equivalent hypoglycemia in normal females
Davis, S. N., Cherrington, A. D., Goldstein, R. E., Jacobs, J., & Price, L. (1993) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1993.265.5.e680 · Cited by 69
GALASSETTI, P., & DAVIS, S. N. (2000) · Clinical Science · doi:10.1042/cs0990351 · Cited by 72
Tse, T. F., Clutter, W. E., Shah, S. D., Miller, J. P., & Cryer, P. E. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110966 · Cited by 68
Self-citationPhillippe, M. (1983) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(83)91088-8 · Cited by 34
Karimian, N., Qin, T., Liang, T., Osundiji, M., Huang, Y., Teich, T., Riddell, M. C., Cattral, M. S., Coy, D. H., Vranic, M., et al. (2013) · Diabetes · doi:10.2337/db13-0164 · Cited by 66
Bolli, G., De Feo, P., Perriello, G., De Cosmo, S., Compagnucci, P., Santeusanio, F., Brunetti, P., & Unger, R. H. (1984) · Journal of Clinical Investigation · doi:10.1172/jci111315 · Cited by 64
Exaggerated epinephrine responses to hypoglycemia in normal and insulin-dependent diabetic children
Amiel, S. A., Simonson, D. C., Sherwin, R. S., Lauritano, A. A., & Tamborlane, W. V. (1987) · The Journal of Pediatrics · doi:10.1016/s0022-3476(87)80393-1 · Cited by 63
Relation of Counterregulatory Responses to Hypoglycemia in Type I Diabetics
Polonsky, K., Bergenstal, R., Pons, G., Schneider, M., Jaspan, J., & Rubenstein, A. (1982) · New England Journal of Medicine · doi:10.1056/nejm198210283071802 · Cited by 64
Hoelzer, D. R., Dalsky, G. P., Clutter, W. E., Shah, S. D., Holloszy, J. O., & Cryer, P. E. (1986) · Journal of Clinical Investigation · doi:10.1172/jci112279 · Cited by 62
Self-citationRetractedRole of the Decrement in Intraislet Insulin for the Glucagon Response to Hypoglycemia in Humans
Gosmanov, N. R., Szoke, E., Israelian, Z., Smith, T., Cryer, P. E., Gerich, J. E., & Meyer, C. (2005) · Diabetes Care · doi:10.2337/diacare.28.5.1124 · Cited by 61
“is considered to be most important (1,2).”
Self-citationCatecholamines in prevention of hypoglycemia during exercise in humans
Marker, J. C., Hirsch, I. B., Smith, L. J., Parvin, C. A., Holloszy, J. O., & Cryer, P. E. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.5.e705 · Cited by 60
Self-citationRickels, M. R., Schutta, M. H., Mueller, R., Kapoor, S., Markmann, J. F., Naji, A., & Teff, K. L. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2426 · Cited by 59
Prolactin, growth hormone and thyrotropin-thyroid hormone secretion during stress states in man
Delitala, G., Tomasi, P. A., & Virdis, R. (1987) · Baillière s Clinical Endocrinology and Metabolism · doi:10.1016/s0950-351x(87)80069-1 · Cited by 57
Metadata
- Authors
- Rizza, R. A., Cryer, P. E., & Gerich, J. E.
- Affiliations
- Mayo Clinic (US)
- Venue
- Journal of Clinical Investigation
- Published
- 1979-07-01
- Volume
- 64
- Issue
- 1
- Pages
- 62-71
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC372091
- OpenAlex
- W1600232156
- Semantic Scholar
- 11f4079b84a608bc5984f3e84f9d0ccc73640319
- Cited by
- 421
- References
- 53
- Citations by year
- 2026: 2 · 2025: 1 · 2024: 5 · 2023: 7 · 2022: 4 · 2021: 5 · 2020: 8 · 2019: 5 · 2018: 12 · 2017: 2 · 2016: 6 · 2015: 8 · 2014: 5 · 2013: 11 · 2012: 3
- FWCI
- 32.10
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Growth Hormone and Insulin-like Growth Factors
- Keywords
- glucose counterregulation, insulin-induced hypoglycemia, glucagon, growth hormone, catecholamines, epinephrine, somatostatin, glucose appearance, glucose disappearance, glucose production, cortisol, adrenergic blockade, phentolamine, propranolol, glucose flux, glucagon deficiency, growth hormone deficiency
- MeSH terms
- Adrenergic alpha-Antagonists, Adrenergic beta-Antagonists, Adult, Blood Glucose, Catecholamines, Drug Interactions, Female, Glucagon, Humans, Hypoglycemia, Insulin, Male, Middle Aged, Phentolamine, Propranolol, Somatostatin, Growth Hormone
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.